Atlas Trials

ADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract Cancer

Clinical trial NCT01825603 · COMPLETED

Trial details

NCT number
NCT01825603
Sponsor
University of Nebraska
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Ampulla of Vater AdenocarcinomaGallbladder AdenocarcinomaMetastatic Pancreatic AdenocarcinomaPancreatic AdenocarcinomaStage III Ampulla of Vater CancerStage III Intrahepatic CholangiocarcinomaStage III Pancreatic CancerStage IIIA Gallbladder CancerStage IIIA Hilar CholangiocarcinomaStage IIIB Gallbladder CancerStage IIIB Hilar CholangiocarcinomaStage IV Ampulla of Vater Cancer
Start date
2013-04-09
Primary completion
2017-06-01
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.